Literature DB >> 24060687

Specificity of miR-378a-5p targeting rodent fibronectin.

Fengqiong Liu1, Qing Lv2, William W Du3, Haoran Li3, Xiangling Yang3, Danyang Liu3, Zhaoqun Deng3, Wenhua Ling4, Yaou Zhang5, Burton B Yang6.   

Abstract

One criterion for microRNA identification is based on their conservation across species, and prediction of miRNA targets by empirical approaches using computational analysis relies on the presence of conservative mRNA 3'UTR. Because most miRNA target sites identified are highly conserved across different species, it is not clear whether miRNA targeting is species-specific. To predict miRNA targeting, we aligned all available fibronectin 3'UTRs and observed significant conservation of all 20 species. Twelve miRNAs were predicted to target most fibronectin 3'UTRs, but rodent fibronectin showed potential binding sites specific for five different miRNAs. One of them, the miR-378a-5p, contained a complete matching seed-region for all rodent fibronectin, which could not be found in any other species. We designed experiments to test whether the species-specific targeting possessed biological function and found that expression of miR-378a-5p decreased cancer cell proliferation, migration, and invasion, resulting in inhibition of tumor growth. Silencing fibronectin expression produced similar effects as miR-378a-5p, while transfection with a construct targeting miR-378-5p produced opposite results. Tumor formation assay showed that enhanced expression of fibronectin in the stromal tissues as a background environment suppressed tumor growth, while increased fibronectin expression inside the tumor cells promoted tumor growth. This was likely due to the different signaling direction, either inside-out or outside-in signal. Our results demonstrated that species-specific targeting by miRNA could also exert functional effects. Thus, one layer of regulation has been added to the complex network of miRNA signaling.
© 2013.

Entities:  

Keywords:  3′-UTR; 3′-untranslated region; 3′UTR; DMEM; Dulbecco's modified Eagle's medium; FBS; Fibronectin; GFP; Invasion; MicroRNA; Species specificity; fetal bovine serum; green fluorescent protein; miRNA; microRNA; siRNA; small interfering RNA

Mesh:

Substances:

Year:  2013        PMID: 24060687     DOI: 10.1016/j.bbamcr.2013.09.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  microRNA Regulation of Skeletal Development.

Authors:  Steven R Sera; Nicole I Zur Nieden
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

2.  Inhibition of Dexamethasone-induced Fatty Liver Development by Reducing miR-17-5p Levels.

Authors:  William W Du; Fengqiong Liu; Sze Wan Shan; Xindi Cindy Ma; Shaan Gupta; Tianru Jin; David Spaner; Sergey N Krylov; Yaou Zhang; Wenhua Ling; Burton B Yang
Journal:  Mol Ther       Date:  2015-04-21       Impact factor: 11.454

3.  Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells.

Authors:  Faizan H Khan; Vijayabaskar Pandian; Satishkumar Ramraj; Sheeja Aravindan; Terence S Herman; Natarajan Aravindan
Journal:  BMC Genomics       Date:  2015-07-07       Impact factor: 3.969

4.  Anti-microRNA-378a enhances wound healing process by upregulating integrin beta-3 and vimentin.

Authors:  Haoran Li; Leslie Chang; William W Du; Shaan Gupta; Azam Khorshidi; Michael Sefton; Burton B Yang
Journal:  Mol Ther       Date:  2014-06-23       Impact factor: 11.454

5.  MicroRNA-17 inhibits tumor growth by stimulating T-cell mediated host immune response.

Authors:  Haoran Li; Shaan Gupta; William W Du; Burton B Yang
Journal:  Oncoscience       Date:  2014-07-27

6.  MicroRNA-4722-5p and microRNA-615-3p serve as potential biomarkers for Alzheimer's disease.

Authors:  Yan Liu; Yuhao Xu; Ming Yu
Journal:  Exp Ther Med       Date:  2022-01-26       Impact factor: 2.447

Review 7.  The Role of miR-378a in Metabolism, Angiogenesis, and Muscle Biology.

Authors:  Bart Krist; Urszula Florczyk; Katarzyna Pietraszek-Gremplewicz; Alicja Józkowicz; Jozef Dulak
Journal:  Int J Endocrinol       Date:  2015-12-29       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.